Expert Video - Which MDS genetic mutations are most likely to cause relapse?
Valeria Santini, MD, an expert on MDS and Associate Professor of Hematology at the University of Florence, describes how some mutations, such as a mutation on the TP53 gene, are linked to a greater likelihood of relapse after MDS treatment. She discusses the effect of having several mutations and how mutations arising during the course of myelodysplastic syndromes (MDS) can lead to treatment resistance.
Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about MDS which will help other patients, caregivers and families.
Other Modules:
Animation - Understanding Genetic Mutations in MDS
Slide Show - Understanding Genetic Mutations in MDS
1.
What is a genetic mutation, a biomarker, and cytogenetic analysis in MDS?
2.
Why is understanding genetic mutations and cytogenetics in MDS important?
3.
Is an MDS-related genetic mutation something I was born with or something that occurred later on?
4.
How do my genetic mutations influence MDS risk?
5.
How does genetic testing help in MDS diagnosis?
6.
How is genetic testing for MDS carried out?
7.
Which genetic mutations and cytogenetic changes have a more favorable response to MDS treatment?
8.
Which genetic mutations and cytogenetic changes have a less favorable response to MDS treatment?
9.
Which MDS genetic mutations are most likely to cause relapse?
10.
What questions should I ask my doctor about MDS genetic testing?
11.
Becky's story: What is your MDS gene mutation profile? When and how were you tested for it?
12.
Donna's story: What is your MDS gene mutation profile? When and how were you tested for it?
13.
Holly's story: What is your MDS gene mutation profile? When and how were you tested for it?
14.
Becky's story: What advice do you have for other MDS patients about genetic testing?
15.
Donna's story: What advice do you have for other MDS patients about genetic testing?
16.
Holly's story: What advice do you have for other MDS patients about genetic testing?
